Avodart (dutasteride), a new drug for benign prostatic hyperplasia (BPH)

GlaxoSmithKline is now marketing Avodart (dutasteride), a new drug for benign prostatic hyperplasia (BPH). ...

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login